Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2017-10-30

How to develop vaccines and medicines that prevent and treat respiratory syncytial virus (RSV) infection

View source ↗

Summary

EMA guidance outlining considerations for developing vaccines and medicines to prevent and treat respiratory syncytial virus (RSV) infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications